Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
san francisco blog main
san francisco top stories
abaloparatide
amgen
avapritinib
bempedoic acid
blueprint medicines
boston
boston blog main
boston top stories
business
business sponsored company news
cholesterol
corticosteroids
cstone pharmaceuticals
deals
detroit
detroit blog main
detroit top stories
eli lilly
esperion therapeutics
europe blog main
europe top stories
european commission
european medicines agency
ezetimibe
fisogatinib
flatiron health
fluoroquinolones
genentech
hepatocellular carcinoma
investing
jeff albers
medullary thyroid cancer
national
What
drug
4
×
wins
4
×
approval
fda
marketing
medicines
nod
regulatory
air
america's
amgen
amgen’s
announced
approved
association
avoidable
awarded
benefit
blueprint
cancer
candidate
carries
cholesterol
combo
contract
costs
currently
developed
diverse
dynamic
esperion
esperion’s
europe
european
heart
impacted
international
levels
lowering
management
Language
unset
Current search:
wins
×
drug
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@venturebeat.com
6 years ago
RxAdvance Wins SMART Union Pharmacy Benefit Management (PBM) Contract to Reduce Overall Pharmacy Costs, Avoidable Drug-Impacted Medical Costs, and Optimize Specialty Drug Utilization